Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

ABT

Abitare In (ABT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
DataOraFonteTitoloSimboloCompagnia
01/07/200901:00Dow Jones News3rd UPDATE: FDA Panel For Eliminating Some Acetaminophen ProductsBIT:ABTAbbott Laboratories
30/06/200922:20Dow Jones News2nd UPDATE: FDA Panel For Eliminating Some Acetaminophen ProductsBIT:ABTAbbott Laboratories
30/06/200917:41Dow Jones NewsReport: Cost Should Play Role In Comparing Medical TreatmentsBIT:ABTAbbott Laboratories
23/06/200914:00PR Newswire (US)Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership PositionBIT:ABT
19/06/200916:48Dow Jones NewsFDA Staff Recommends Updated Warning For AsmanexBIT:ABTAbbott Laboratories
12/06/200916:50PR Newswire (US)Abbott Declares 342nd Consecutive Quarterly DividendBIT:ABT
10/06/200918:11Dow Jones NewsAbbott CEO: No Interest In Large, 'Mega-Deal' MergersBIT:ABTAbbott Laboratories
09/06/200919:09Dow Jones NewsSuccessful TriLipix Trials Good News For Solvay - AnalystsBIT:ABTAbbott Laboratories
09/06/200917:30Dow Jones NewsIN THE PIPELINE: Less Is More In Boston Sci Stent PlansBIT:ABTAbbott Laboratories
08/06/200900:41Dow Jones NewsCORRECT: Large Study Questions Value Of StentsBIT:ABTAbbott Laboratories
08/06/200900:33Dow Jones NewsUPDATE: Large Study Questions Value Of StentsBIT:ABTAbbott Laboratories
08/06/200900:03Dow Jones NewsLarge Study Questions Value Of StentsBIT:ABTAbbott Laboratories
04/06/200914:20Dow Jones NewsAstraZeneca, Abbott Submitted New Drug Application To The FDABIT:ABTAbbott Laboratories
01/06/200916:08PR Newswire (US)Abbott to Present at Goldman Sachs Global Healthcare ConferenceBIT:ABT
29/05/200917:32PR Newswire (US)Abbott Named One of the Top 10 Companies for ScientistsBIT:ABT
29/05/200917:08Dow Jones NewsFDA:Advanced Life's Restanza Has No Unexpected Side EffectsBIT:ABTAbbott Laboratories
26/05/200918:34Dow Jones NewsAbbott Heart Drug Faces Key Test In Large US StudyBIT:ABTAbbott Laboratories
22/05/200922:34Dow Jones NewsDrug Makers To Pay $89 Million To Settle Alabama Medicaid Price SuitsBIT:ABTAbbott Laboratories
22/05/200922:34Dow Jones NewsFDA: Doctors Must Tell People About Lasik Eye Surgery RisksBIT:ABTAbbott Laboratories
22/05/200901:00Dow Jones NewsFenofibrate Cuts Amputation Risk For Type 2 Diabetics -StudyBIT:ABTAbbott Laboratories
21/05/200915:30Dow Jones NewsAbbott: Low Event Rates In Big One-Year Stent StudyBIT:ABTAbbott Laboratories
19/05/200920:45Dow Jones NewsUPDATE: J&J: New Stent Outperforms Rival Device In TrialBIT:ABTAbbott Laboratories
19/05/200916:05Dow Jones NewsJ&J: New 'Nevo' Stent Outperforms Rival Device In TrialBIT:ABTAbbott Laboratories
07/05/200919:08Dow Jones NewsHealth-Care Stocks Rally On Hopes For Bipartisan ReformBIT:ABTAbbott Laboratories
06/05/200918:22Dow Jones NewsAbbott Files Patent-Infringement Suit Vs. J&J Over SimponiBIT:ABTAbbott Laboratories
04/05/200917:59Dow Jones NewsMedicare Changes Benign For Device Cos, But Pressure LoomsBIT:ABTAbbott Laboratories
27/04/200919:40PR Newswire (US)Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship ReportBIT:ABT
24/04/200917:21PR Newswire (US)Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong OutlookBIT:ABT
24/04/200901:06Dow Jones News2nd UPDATE: Amgen 1Q Profit Drops 7.4%; Cuts '09 Revenue ViewBIT:ABTAbbott Laboratories
24/04/200900:23Dow Jones NewsUPDATE: Amgen 1Q Profit Drops 7.4%; Cuts '09 Revenue ViewBIT:ABTAbbott Laboratories
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network